Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice ; volume:9 ; number:1 ; day:23 ; month:5 ; year:2008 ; pages:1-9 ; date:12.2008
Respiratory research ; 9, Heft 1 (23.5.2008), 1-9, 12.2008
- Urheber
-
Waseda, Yuko
- Beteiligte Personen und Organisationen
-
Yasui, Masahide
Nishizawa, Yoriko
Inuzuka, Kanako
Takato, Hazuki
Ichikawa, Yukari
Tagami, Atsuro
Fujimura, Masaki
Nakao, Shinji
SpringerLink (Online service)
- DOI
-
10.1186/1465-9921-9-43
- URN
-
urn:nbn:de:1111-201606038634
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Waseda, Yuko
- Yasui, Masahide
- Nishizawa, Yoriko
- Inuzuka, Kanako
- Takato, Hazuki
- Ichikawa, Yukari
- Tagami, Atsuro
- Fujimura, Masaki
- Nakao, Shinji
- SpringerLink (Online service)
Ähnliche Objekte (12)
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Bleomycin-induced genome structural variations in normal, non-tumor cells
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Bortezomib restrains M2 polarization and reduces CXCL16-associated CXCR6+CD4 T cell chemotaxis in bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Bleomycin-induced genome structural variations in normal, non-tumor cells
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Bortezomib restrains M2 polarization and reduces CXCL16-associated CXCR6+CD4 T cell chemotaxis in bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Bleomycin-induced genome structural variations in normal, non-tumor cells
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Bortezomib restrains M2 polarization and reduces CXCL16-associated CXCR6+CD4 T cell chemotaxis in bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis